The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Lilly (Eli) & Co (LLY)

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations.

Eli Lilly SEC Filing Email Alerts Service

Company Name:  Lilly (Eli) & Co
Stock buyback:  LLY buyback
Website:  www.lilly.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding LLY:  121
Total Market Value Held by ETFs:  $78.45B
Total Market Capitalization:  $739.40B
% of Market Cap. Held by ETFs:  10.61%
March 29, 2024    12:00 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree LLY Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.79 out of 4)
71st percentile
(ranked higher than approx. 71% of all stocks covered)

Analysts' Target Price:
LLY Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Lilly (Eli) & Co (LLY) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.